258 related articles for article (PubMed ID: 34183355)
1. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K.
Khan IZ; Del Guzzo CA; Shao A; Cho J; Du R; Cohen AO; Owens DM
Cancer Res; 2021 Oct; 81(19):5021-5032. PubMed ID: 34183355
[TBL] [Abstract][Full Text] [Related]
2. CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-κB signaling in cervical cancer.
Mou J; Zheng W; Wei D; Li D; Fan R; Tang Q
Heliyon; 2023 Aug; 9(8):e19220. PubMed ID: 37654464
[TBL] [Abstract][Full Text] [Related]
3. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
4. CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma.
Belkin DA; Mitsui H; Wang CQ; Gonzalez J; Zhang S; Shah KR; Coats I; Suàrez-Fariñas M; Krueger JG; Felsen D; Carucci JA
JAMA Dermatol; 2013 Feb; 149(2):178-86. PubMed ID: 23560298
[TBL] [Abstract][Full Text] [Related]
5. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
Liu JQ; Talebian F; Wu L; Liu Z; Li MS; Wu L; Zhu J; Markowitz J; Carson WE; Basu S; Bai XF
J Immunol; 2016 Aug; 197(4):1489-97. PubMed ID: 27385779
[TBL] [Abstract][Full Text] [Related]
6. The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
Stumpfova M; Ratner D; Desciak EB; Eliezri YD; Owens DM
Cancer Res; 2010 Apr; 70(7):2962-72. PubMed ID: 20332223
[TBL] [Abstract][Full Text] [Related]
7. CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts.
Cui W; Cuartas E; Ke J; Zhang Q; Einarsson HB; Sedgwick JD; Li J; Vignery A
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14436-41. PubMed ID: 17726108
[TBL] [Abstract][Full Text] [Related]
8. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.
Liu JQ; Hu A; Zhu J; Yu J; Talebian F; Bai XF
Adv Exp Med Biol; 2020; 1223():155-165. PubMed ID: 32030689
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms of CD200-CD200R induce diverse outcomes in cancer treatment.
Liao KL; Watt KD; Protin T
Math Biosci; 2023 Nov; 365():109072. PubMed ID: 37734537
[TBL] [Abstract][Full Text] [Related]
10. Centrin-Deleted
Singh RK; Gannavaram S; Ismail N; Kaul A; Gedda MR; Nakhasi HL
Front Immunol; 2018; 9():1176. PubMed ID: 29915577
[TBL] [Abstract][Full Text] [Related]
11. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?
Minas K; Liversidge J
Crit Rev Immunol; 2006; 26(3):213-30. PubMed ID: 16928187
[TBL] [Abstract][Full Text] [Related]
12. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies.
Pilch Z; Tonecka K; Skorzynski M; Sas Z; Braniewska A; Kryczka T; Boon L; Golab J; Meyaard L; Rygiel TP
PLoS One; 2019; 14(1):e0210796. PubMed ID: 30653571
[TBL] [Abstract][Full Text] [Related]
13. Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell Carcinoma.
Li L; Tian Y; Shi C; Zhang H; Zhou Z
Med Sci Monit; 2016 Apr; 22():1079-84. PubMed ID: 27035797
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.
Pilch Z; Tonecka K; Braniewska A; Sas Z; Skorzynski M; Boon L; Golab J; Meyaard L; Rygiel TP
Cancer Immunol Res; 2018 Aug; 6(8):930-940. PubMed ID: 30021725
[TBL] [Abstract][Full Text] [Related]
15. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue.
Stack G; Jones E; Marsden M; Stacey MA; Snelgrove RJ; Lacaze P; Jacques LC; Cuff SM; Stanton RJ; Gallimore AM; Hussell T; Wilkinson GW; Ghazal P; Taylor PR; Humphreys IR
PLoS Pathog; 2015 Feb; 11(2):e1004641. PubMed ID: 25654642
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
17. CD200 receptor controls sex-specific TLR7 responses to viral infection.
Karnam G; Rygiel TP; Raaben M; Grinwis GC; Coenjaerts FE; Ressing ME; Rottier PJ; de Haan CA; Meyaard L
PLoS Pathog; 2012; 8(5):e1002710. PubMed ID: 22615569
[TBL] [Abstract][Full Text] [Related]
18. Regulation of myeloid cell function through the CD200 receptor.
Jenmalm MC; Cherwinski H; Bowman EP; Phillips JH; Sedgwick JD
J Immunol; 2006 Jan; 176(1):191-9. PubMed ID: 16365410
[TBL] [Abstract][Full Text] [Related]
19. The CD200-CD200 receptor inhibitory axis controls arteriogenesis and local T lymphocyte influx.
van den Borne P; Rygiel TP; Hoogendoorn A; Westerlaken GH; Boon L; Quax PH; Pasterkamp G; Hoefer IE; Meyaard L
PLoS One; 2014; 9(6):e98820. PubMed ID: 24897500
[TBL] [Abstract][Full Text] [Related]
20. Ligation of CD200R by CD200 is not required for normal murine myelopoiesis.
Rijkers ES; de Ruiter T; Buitenhuis M; Veninga H; Hoek RM; Meyaard L
Eur J Haematol; 2007 Nov; 79(5):410-6. PubMed ID: 17803680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
